NVS Message Board Post 9267158 | Novartis AG
home / stock / nvs / nvs message board
(investorshub)
Posted on: May/24/2019 17:20:40
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149018982
News: $NVS AveXis receives FDA approval for Zolgensma®,
News, Short Squeeze, Breakout and More Instantly...
Novartis AG Company Name:
NVS Stock Symbol:
Market:
-
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio PR Newswire In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demons...
-
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo PR Newswire Secondary endpoint data for estimated glomerular filtration rate (eGF...